Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore enhancements to budgeting strategies and adopt practical tweaks to optimize spending and savings.
20,040 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A memory stock that looked ordinary just a year ago has stunned investors with an 8x move. Now Wall Street is unanimo...
A routine call spirals into a gold handoff for supposed government verification. Learn how the scam works, the warnin...
Looking for fast-growing industrial mid-cap stocks with durable revenue streams? This guide breaks down two compellin...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
No stock goes straight up, and Walmart’s latest report is a perfect example. Strong e-commerce gains meet a cautious ...
A sharp rally inAehr Test Systems has investors wondering what's next. This article breaks down the catalysts, the bu...
Rigetti Computing shares jumped this week as momentum in quantum tech paired with company milestones. Learn the catal...
Looking to find a better space stock: spacemobile? This guide breaks down AST SpaceMobile and Rocket Lab, weighing te...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
Big tech often steals the AI spotlight, but overlooked, nimble players could outperform. This guide breaks down the r...